Senior insider sale
EVP, Global Research and CSO at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$1.55M
3.23K shares
What this filing means
ALTSHULER DAVID plans to sell 3.23K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $1.55M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/27/2025ACC: 0001959173-25-001407
Officer· EVP, Global Research and CSO
Since Jun 2018
3.23K
Shares to sell
$1.55M
Approx. market value
1.27K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/26/2025
1.27KTotal acquired1.27K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/26/2025 | Restricted Stock Vesting Compensation | 1.27K | — |
| Total | 1.27K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
848.00
Market value
$407.8K
2/25/2025
—Completed
Units to sell
1.11K
Market value
$533.3K
2/20/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.27K
Market value
$610.6K
2/27/2025
Total
Units
3.23K
Value
$1.55M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/25/2025 | 848.00 | $407.8K | — | Completed |
2/20/2025 | 1.11K | $533.3K | — | Completed |
| Planned — Approximate Date | ||||
2/27/2025 | 1.27K | $610.6K | NASDAQ | Planned |
| Total | 3.23K | $1.55M | ||